Complex partial status epilepticus associated with cyclosporin A therapy.
Open Access
- 1 September 1989
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 52 (9), 1068-1071
- https://doi.org/10.1136/jnnp.52.9.1068
Abstract
Significant neurotoxicity including seizures, encephalopathy and coma may complicate the use of cyclosporin A (CyA). Two patients are described, receiving CyA, who presented with abnormal behaviour, stupor, focal motor activity and were shown to be in complex partial status epilepticus (CPSE). Abnormalities of behaviour and/or stupor in patients receiving CyA may be a manifestation of CPSE. Patients receiving CyA who develop an encephalopathy should have electroencephalography performed at the time of the abnormal behaviour.This publication has 19 references indexed in Scilit:
- Complex Partial Status EpilepticusPsychiatry and Clinical Neurosciences, 1988
- CYCLOSPORIN METABOLITES AND CENTRAL-NERVOUS-SYSTEM TOXICITYThe Lancet, 1988
- SEVERE CENTRAL-NERVOUS-SYSTEM TOXICITY ASSOCIATED WITH CYCLOSPORINThe Lancet, 1985
- CYCLOSPORIN-ASSOCIATED FATAL CONVULSIONSThe Lancet, 1985
- HYPOMAGNESAEMIA AND CYCLOSPORIN TOXICITYThe Lancet, 1985
- CYCLOSPORINE-ASSOCIATED CENTRAL NERVOUS SYSTEM TOXICITY AFTER RENAL TRANSPLANTATIONTransplantation, 1985
- The Infant Seat as Treatment for Gastroesophageal RefluxNew England Journal of Medicine, 1984
- Cyclosporine-Associated Central-Nervous-System Toxicity after Allogeneic Bone-Marrow TransplantationNew England Journal of Medicine, 1984
- CYCLOSPORIN A, METHYLPREDNISOLONE, AND CONVULSIONSThe Lancet, 1982
- Complex partial status epilepticus in young childrenAnnals of Neurology, 1981